Copyright
©The Author(s) 2023.
World J Clin Oncol. Aug 24, 2023; 14(8): 311-323
Published online Aug 24, 2023. doi: 10.5306/wjco.v14.i8.311
Published online Aug 24, 2023. doi: 10.5306/wjco.v14.i8.311
Figure 1 Coronavirus disease 2019 status of index and readmitted case for 30-days and 90-days readmission cohort, 2020.
COVID-19: Coronavirus disease 2019; DRC: Day readmission cohort.
Figure 2 Top five causes of 30-days readmission for inpatient chemotherapy during coronavirus disease 2019 pandemic, Nationwide Readmission Database, 2020.
Figure 3 Comparison of Mortality Between Index Admission and Readmission in 30-days and 90-days readmission cohort, Nationwide Readmission Database, 2020.
Figure 4 Kaplan-Meier curve for 90-readmision, Nationwide Readmission Database, 2023.
COVID: Coronavirus disease.
- Citation: Kanemo P, Musa KM, Deenadayalan V, Litvin R, Odeyemi OE, Shaka A, Baskaran N, Shaka H. Readmission rates and outcomes in adults with and without COVID-19 following inpatient chemotherapy admission: A nationwide analysis. World J Clin Oncol 2023; 14(8): 311-323
- URL: https://www.wjgnet.com/2218-4333/full/v14/i8/311.htm
- DOI: https://dx.doi.org/10.5306/wjco.v14.i8.311